Page 9 - Read Online
P. 9

Wang et al. J Transl Genet Genom 2023;7:126-40  https://dx.doi.org/10.20517/jtgg.2023.07  Page 130

               Table 1. Primer sequences used for qRT-PCR
                       Genes       Forward primers (5′-3′)           Reverse sequence (5′-3′)
                lncRNA  LncADAM9   TACATACAATGGTCAGATGGCAAA          GCCTTGATGGGAACTGCTGA
                       LncPCDH10   TGAGGGAACAGGTTCTCTATGGT           TGTGTGGTTCTGATGTGTCTCCTAC
                       lncUSP46    CGGGGACGATCAGTCACATAAG            CGTGCTGGGATTGGTCATAGTT
                mRNA   ADAM9       GCCACTGGGAATGCTTTGT               GCAGTATTCATTTCATTGTATGTAGGT
                       PCDH10      TGTCCAACGAGACTAAACACCAG           CTATCTCCCTGTTCACTGTCTCCAT
                       USP46       AGAAGCCCAGAAAAGGATGAGG            GAACGACCACCGCAACCAA
                       CADM1       CCACAGGAAAGTTACACCACCAT           CACCTCCGATTTGCCTTTTAG
                       CD274       CAATGTGACCAGCACACTGAGA            CAGTGCTACACCAAGGCATAATAAG
                       CLDN7       AGGGGCTGTGGATGGACTG               GCCTTCTTCACTTTGTCGTCTC
                       CNTN1       ATAGAAGTCCCAATCCCCAGAGA           GGGTGCACCTGAAATTTTGACT
                       HLA-DPB1    CGGAGTAAGACATTGACGGG              CTCGTTGAACTTTCTTGCTCCT
                       ICAM2       TCCAGGATCGGATGAGAAGGTA            GGAGATGTTTGAGACCAAGTAATG
                       ITGAL       AGCAGCAAGCATTTCCACCT              GGATTCCATTCGGGACACCT
                       NRXN2       AGAACCAGGCATCCCTCCCT              AGATGCCGGCTTCCCTCAG
                       SELL        ACTGGGATTGAAGAAACCACCTG           CCAGGGGATGGCTACAGTTCA
                       SIGLEC1     CTCTGTCACCTTCAACAGCCAGA           TGGGGGCATACTTCACTTGGA
                       CADM3       ACCCTCAATGTTAATGACCCCA            AGGAAGACAATGAAAGCCACG
                       MPZL1       GCTTGGGCTCTTGACAGCT               GTCAACCCGCCAGTCGTA
                       SPN         CCTTGGGGTGCTGGTGGTA               GAGGTAGGGCTGAGGTCTGGTC
                       CLDN10      TCATACTGTCAGGGCTGTGCTC            CTCCTGCCCATCCAATAAACA
                       ICAM3       CGAGTCCTGTATGGTCCCAAAAT           CGTGTCTCGTTTTATCTTTCCATT
                       ITGB7       CTCTGCGGAGGCTTTGGT                ACCATAGTAGCCGTCCAAGCA
                       GAPDH       TTGGCTACAGCAACAGGGTG              GGGGAGATTCAGTGTGGTGG


               antibodies (Abcam, Cambridge, MA), which are against eight proteins that are involved in the ECM-A
               pathway and are differentially expressed in sPTB, were diluted to 1:1,000, and the peroxidase-conjugated
               secondary antibody (Abcom), to 1:5,000. The bands were detected by chemiluminescence signals by using
               ECL Western Blotting Substrate (Thermo Fisher) and scanned to produce digital images. GAPDH served as
               an internal control.

               Statistical analysis
               For quantification of RNAs, ∆Ct = Cttarget - Ctreference was computed for each sample. ∆Ct values,
               surrogates for RNA abundance in each sample, were compared between groups using an unpaired, two-
               tailed t-test. Differences in DEP were considered significant at P < 0.05. The final result was finally reported
               as relative expression by setting the expression value in the control group as “1”. The expression value in the
               case group was calculated in relation to the control group. All data were given in terms of relative
               expression of mean ± SD. The data were subjected to one-way ANOVA, followed by an unpaired, two-tailed
               t-test.


               RESULTS
               Human placental incRNAs associated with ECM-A pathway
               The original transcriptomic profile with identification of differentially expressed lncRNAs was deposited in
               Gene  Expression  Omnibus  with  an  accession  number  GSE  50879  (Available  from:  http://
               www.ncbi.nlm.nih.gov/geo/info/linking.html). Transcriptomic analysis of chorionic villi from 40 human
               placenta samples (10 from each subgroup) showed that significant up-regulation of lncADAM9 in pPROM
               and sPTL as compared to samples from either FTB or PROM [Figure 1].
   4   5   6   7   8   9   10   11   12   13   14